Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Regina Paleski
China and Asia-focused Everest Medicines has poached a handful of senior hires from Sanofi, Abbott and Amgen, while Gilead Sciences’ new chief medical officer Merdad Parsey joins from Genentech.
Midatech Pharma and Retrophin – both developing therapies for rare diseases – appoint CFO and chief commercial officer, respectively. Meanwhile, genomic medicine company Sangamo Therapeutics hires a CMO.
EMD Serono welcomes SVP, North American medical affairs while ophthalmic products company SIFI SpA announces country manager, Italy and. At Acino International a new global head for IT is now on board.
Executives On The Move: Menarini Group Chooses Next CEO, Crescendo Decides On A CBO And Scholar Rock Adds Head, Medical Research
At Italian Biopharma Menarini Group a former Merck KGaA head of new business is now CEO. Oncology therapeutics firm Crescendo Biologics picks GSK exec as CBO and Biogen medical director is now a Medical Research Head at clinical-stage biopharma Scholar Rock.
Recent appointments at executive level in pharmaceutical and biotech companies include new CEOs at RhoVac AB, Step Pharma and Ascendis Health, a new chief business officer at MaaT Pharma, and a new chief scientific officer at Pieris Pharmaceuticals.
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.